PHILADELPHIA, PA USA (Press Release) - August 13, 2012 - A popular class of diabetes drugs increases patients’ risk of bladder cancer, according to a new study published online this month in the Journal of the National Cancer Institute.
To read more, a FREE Urotoday registration is required. Click here to register or login above.
To read UIJ content, a separate subscription is required.
website design firm : Web-JIVE LLC